Study identifier: NCT05147792 Synced from ClinicalTrials.gov · August 05, 2026
● Recruiting

The CONFORM Pivotal Trial

Condition: Atrial Fibrillation · Stroke  ·  Sponsor: Conformal Medical, Inc

PhaseNA
Planned participants1600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The CLAAS® device will be evaluated for safety and efficacy by establishing its performance is non-inferior to the commercially available WATCHMAN® and Amulet™ left atrial appendage closure devices in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the CLAAS device or the WATCHMAN or Amulet™ devices and will be followed for 5 years after device implant.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Gallagher  ·  952-270-8356  ·  sgallagher@conformalmedical.com

Always discuss trial participation with your own doctor first.

Locations (93)

Grandview Medical CenterBirmingham, Alabama, United StatesRecruiting
Banner University Medical Center PhoenixPhoenix, Arizona, United StatesRecruiting
Abrazo Arizona Heart HospitalPhoenix, Arizona, United StatesActive Not Recruiting
Arizona Heart Arrhythmia AssociatesPhoenix, Arizona, United StatesRecruiting
HonorHealthScottsdale, Arizona, United StatesRecruiting
Pima Heart & VascularTucson, Arizona, United StatesRecruiting
St. Bernard's Medical CenterJonesboro, Arkansas, United StatesRecruiting
Loma Linda University HealthLoma Linda, California, United StatesRecruiting
Huntington HospitalPasadena, California, United StatesRecruiting
Pacific Heart InstituteSanta Monica, California, United StatesRecruiting
Community Memorial Hospital VenturaVentura, California, United StatesRecruiting
South Denver Cardiology AssociatesLittleton, Colorado, United StatesRecruiting

+ 81 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →